Scholarlink

Research question <p>Does the use of GnRH agonist trigger versus hCG trigger affect the length of the subsequent follicular phase in women?</p> Design <p>A retrospective cohort study analyzing 196 women undergoing controlled ovarian stimulation with freeze-all for PGT-M at a university-affiliated fertility center; 132 received GnRH agonist trigger, and 64 received hCG trigger.</p> Results <p>The GnRH agonist group demonstrated a significantly longer subsequent follicular phase compared to the hCG group (18.98 ± 3.54 vs. 16.06 ± 3.13&#xa0;days, <i>P</i> &lt; .001), with extended follicular phase occurring in 90.2% versus 60.9% of cycles (<i>P</i> &lt; .001). Both groups had comparable antral follicle counts (14.52 ± 7.71 vs. 13.00 ± 15.36, <i>P</i> = .748). Multiple regression analysis identified GnRH agonist trigger as a significant independent predictor of subsequent follicular phase length (coefficient = 4.552, 95% CI: 3.058–6.045, <i>P</i> &lt; .001), along with BMI (coefficient = 0.188, 95% CI: 0.019–0.357, <i>P</i> = .030). The model explained 31.4% of the variance in follicular phase length (F = 7.516, <i>P</i> &lt; .001). After adjusting for confounding variables, pregnancy rates were comparable between groups (OR = 1.763, 95% CI: 0.798–3.505, <i>P</i> = .173).</p> Conclusions <p>The GnRH agonist trigger prolongs the subsequent follicular phase compared to the hCG trigger without compromising pregnancy rates. BMI showed a statistically significant but modest association with follicular phase length that requires further validation. These findings have important implications for optimizing the timing of frozen embryo transfer in subsequent cycles and may facilitate more personalized monitoring protocols.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of GnRH agonist trigger on subsequent follicular phase length in ART cycles

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月9日

查看全文
  • Roza Berkovitz-Shperling,
  • Yaara Libai,
  • Shir Aviv,
  • Ben-Yosef Dalit,
  • Azem Foad,
  • Feferkorn Ido

摘要

Research question

Does the use of GnRH agonist trigger versus hCG trigger affect the length of the subsequent follicular phase in women?

Design

A retrospective cohort study analyzing 196 women undergoing controlled ovarian stimulation with freeze-all for PGT-M at a university-affiliated fertility center; 132 received GnRH agonist trigger, and 64 received hCG trigger.

Results

The GnRH agonist group demonstrated a significantly longer subsequent follicular phase compared to the hCG group (18.98 ± 3.54 vs. 16.06 ± 3.13 days, P < .001), with extended follicular phase occurring in 90.2% versus 60.9% of cycles (P < .001). Both groups had comparable antral follicle counts (14.52 ± 7.71 vs. 13.00 ± 15.36, P = .748). Multiple regression analysis identified GnRH agonist trigger as a significant independent predictor of subsequent follicular phase length (coefficient = 4.552, 95% CI: 3.058–6.045, P < .001), along with BMI (coefficient = 0.188, 95% CI: 0.019–0.357, P = .030). The model explained 31.4% of the variance in follicular phase length (F = 7.516, P < .001). After adjusting for confounding variables, pregnancy rates were comparable between groups (OR = 1.763, 95% CI: 0.798–3.505, P = .173).

Conclusions

The GnRH agonist trigger prolongs the subsequent follicular phase compared to the hCG trigger without compromising pregnancy rates. BMI showed a statistically significant but modest association with follicular phase length that requires further validation. These findings have important implications for optimizing the timing of frozen embryo transfer in subsequent cycles and may facilitate more personalized monitoring protocols.